Evidence map›Paper›PMID 32588250›Full record

ArticleNeurochemical research2020

Retraction Note to: MicroRNA-322 Cluster Promotes Tau Phosphorylation via Targeting Brain-Derived Neurotrophic Factor.

Jun Zhang, Zanchao Liu, Yuanyuan Pei, Wen Yang, Chicu Xie, Shiqi Long

RetractedOpen access · bronzeAbstract readRetraction Notice
PubMed Publisher
In one paragraph

Article in Neurochemical research, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It has been retracted, and should not be counted. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.1field-weighted citation impact, top 53% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 1 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Jun ZhangDepartment of Pathology, The Affiliated Hospital of Guizhou Medical University, Guiyang, 550004, People's Republic of China.
Zanchao LiuThe Shijiazhuang Second Hospital of Hebei Province, Shijiazhuang, 050051, People's Republic of China.
Yuanyuan PeiDepartment of Pathology, The Affiliated Hospital of Guizhou Medical University, Guiyang, 550004, People's Republic of China.
Wen YangDepartment of Pathology, The Affiliated Hospital of Guizhou Medical University, Guiyang, 550004, People's Republic of China.
Chicu XieDepartment of Immunology, Basic School of Medicine, Guizhou Medical University, Guiyang, 550004, People's Republic of China.
Shiqi LongDepartment of Immunology, Basic School of Medicine, Guizhou Medical University, Guiyang, 550004, People's Republic of China. 767446430@qq.com.
Guiyang Medical University · CNAffiliated Hospital of Guizhou Medical University · CNHospital of Hebei Province · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The Editors have retracted this article [1] following an investigation conducted by the journal. After publication concerns were raised regarding interpretation of the data presented in Fig. 4. The Editors requested additional data and clarification to confirm interpretation of data results. After further review, the Editors found that the additional data were not adequate to support the conclusion of the article and that P-values for the additional data were based on improper statistical analyses. With more appropriate statistical analysis, the reported effects for miR-322 and BDNF were not statistically significant. Dr. Chichu Xie agrees to this retraction. None of the other authors have responded to any correspondence from the publisher about this retraction.

Identifiers

PMID32588250
OpenAlexW3037669149

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.